The chemotherapy response score is a useful histological predictor of prognosis in high‐grade serous carcinoma
Priya Singh(Institute of Macromolecular Chemistry), Radhika Srinivasan(Galgotias University), Pranab Dey(Homi Bhabha National Institute), Nalini Gupta(Post Graduate Institute of Medical Education and Research), Manish Rohilla(Post Graduate Institute of Medical Education and Research), Vanita Suri(Post Graduate Institute of Medical Education and Research), Vikrant Kaushal(Post Graduate Institute of Medical Education and Research), Rashi Garg(Maulana Azad Medical College), Bhavana Rai(Post Graduate Institute of Medical Education and Research), Arvind Rajwanshi(Post Graduate Institute of Medical Education and Research), Sushmita Ghoshal(Post Graduate Institute of Medical Education and Research)
Cited by 48
Related Papers
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
|The Lancet Oncology|2021|624
Dose–effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study
|Radiotherapy and Oncology|2016|216